de la Rosette Jean J M C H, Wink Margot H, Mamoulakis Charalampos, Wondergem Niels, ten Kate Fiebo J C, Zwinderman Koos, de Reijke Theo M, Wijkstra Hessel
Department of Urology, Academic Medical Center, University Hospital, Amsterdam, The Netherlands.
J Urol. 2009 Oct;182(4):1329-36. doi: 10.1016/j.juro.2009.06.037. Epub 2009 Aug 15.
We compared prostate cancer detection rates achieved using an 8 and 12-core biopsy protocol in a clinical population to determine the significance of additional transition zone sampling on repeat biopsy.
Between September 2004 and September 2007, 269 eligible patients with a clinical suspicion of prostate cancer referred to our department were randomized to an 8-core lateral (group 1) or a 12-core lateral and parasagittal (group 2) transrectal ultrasound guided prostate biopsy protocol. Study inclusion criteria were age dependent increased serum prostate specific antigen (1.25 ng/ml or greater at ages less than 50 years, 1.75 or greater at ages 50 to less than 60 years, 2.25 or greater at ages 60 to less than 70 years and 3.25 or greater at ages 70 years or greater), positive digital rectal examination and/or suspicious transrectal ultrasound. After negative first round biopsy patients underwent 12-core biopsy, including 4 transition zone cores.
Nine patients were excluded from analysis because of protocol violation or they did not complete the whole biopsy procedure due to discomfort. The cancer detection rate in groups 1 and 2 did not differ significantly (34.1% or 45 of 132 patients and 38.3% or 49 of 128, respectively, p = 0.48). Detected cancer median Gleason scores were similar in the groups. Of 109 patients who underwent repeat biopsy prostate cancer was detected in 20 (14.4%), of whom 9 had positive cores from the transition zone and 6 had positive biopsies only from the transition zone.
There are no statistically significant differences in the prostate cancer detection rate between 8 and 12-core prostate biopsy protocols. Transition zone biopsies contribute to prostate cancer detection in a repeat biopsy protocol.
我们比较了在临床人群中使用8针和12针活检方案检测前列腺癌的比率,以确定在重复活检时额外对移行区进行采样的意义。
在2004年9月至2007年9月期间,269例临床怀疑患有前列腺癌且转诊至我科的符合条件患者被随机分为两组,一组接受经直肠超声引导下的8针外侧前列腺活检方案(第1组),另一组接受12针外侧及矢状旁前列腺活检方案(第2组)。研究纳入标准为血清前列腺特异性抗原随年龄增长升高(年龄小于50岁时为1.25 ng/ml或更高,50至小于60岁时为1.75或更高,60至小于70岁时为2.25或更高,70岁及以上时为3.25或更高)、直肠指检阳性和/或经直肠超声可疑。首轮活检阴性的患者接受12针活检,包括4针移行区活检。
9例患者因违反方案或因不适未完成整个活检程序而被排除在分析之外。第1组和第2组的癌症检测率无显著差异(分别为132例患者中的34.1%即45例和128例患者中的38.3%即49例,p = 0.48)。两组中检测到的癌症的中位Gleason评分相似。在109例接受重复活检的患者中,20例(14.4%)检测到前列腺癌,其中9例移行区活检阳性,6例仅移行区活检阳性。
8针和12针前列腺活检方案在前列腺癌检测率上无统计学显著差异。在重复活检方案中,移行区活检有助于前列腺癌的检测。